28 results
8-K
EX-99.1
MNPR
Monopar Therapeutics Inc
27 Oct 21
Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating
8:46am
interest and support we are seeing within the oncology community for this study adds to our hopeful excitement and anticipation of the potential
8-K
EX-99.1
cjhoo2tcvq0hagujs7
13 Sep 21
Trial launch in Europe coincides with the Company’s upcoming presentation at the European Society for Medical Oncology Congress
8:05am
DEF 14A
19z139
29 Apr 20
Definitive proxy
12:57pm
424B4
29drqln4o dvg7r
19 Dec 19
Prospectus supplement with pricing info
5:36pm
S-1/A
0yy1aqljk
10 Sep 19
IPO registration (amended)
5:23pm
S-1
rne3 rh9oc8pinmt
15 Aug 19
IPO registration
4:18pm
DEF 14C
skq exrtpq0sq
21 May 19
Information statement
9:35pm